Medicines Substances Companies Statistics

A free, open platform for EU medicines data, based on official EMA data.

Database

Medicines
Substances
Companies

Data Sources

EMA

2026 uMedical - Open Source Project

Imprint
Privacy Policy
Terms
Contact

Flucelvax Tetra

WithdrawnHuman

Details

EMA number	EMEA/H/C/004814
ATC code	J07BB02
Authorisation	12 December 2018
Withdrawn	23 February 2026
Revision	17

Therapeutic indication

Prophylaxis of influenza in adults and children from 2 years of age. Flucelvax Tetra should be used in accordance with official recommendations.

MeSH: Influenza, Human

Group: influenza, inactivated, split virus or surface antigen

Active substances

A/Wisconsin/67/2022 (H1N1)pdm09-like strain (A/Georgia/12/2022, CVR-167) A/Massachusetts/18/2022 (H3N2)-like strain (A/Sydney/1304/2022, wild type) B/Austria/1359417/2021-like strain (B/Singapore/WUH4618/2021, wild type) B/Phuket/3073/2013-like strain (B/Singapore/INFTT-16-0610/2016, wild type)

Marketing Authorisation Holder

Seqirus Netherlands B.V.

Timeline

Filter by authority:

Flucelvax Tetra withdrawn

23 Feb 2026

withdrawnregulatory

Flucelvax Tetra authorised

12 Dec 2018

authorisedregulatory

Flucelvax Tetra | uMedical